TNBC Archives - Onco'Zine

Risk of Recurrence of Triple-Negative Breast Cancer May be Predicted by...

Peter Hofland, Ph.D - April 24, 2020

Watching a mammogram-the result of x-ray examination of the mammary glands for the prevention of breast cancer. Courtesy: Fotolia/Evgeniy Kalinovskiy

Sacituzumab Govitecan Approved in Metastatic Triple-negative Breast Cancer

Peter Hofland, Ph.D - April 22, 2020

Triple negative breast cancer cells showing abnormal expression basal-like markers not found on normal breast epithelial cells. Cells are stained with cytokeratins 14 (green) and 19 (red). Photo courtesy: Bill Schmitt.

Radiation, Inflammation and Triple-Negative Breast Cancer: A Study

Peter Hofland, Ph.D - February 24, 2020

Images of the San Antonio Breast Cancer Symposium (SABCS) being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Photo courtesy © Sunvalley Communication / Evan Wendt

SABCS 2019: Circulating Tumor DNA may be a Predictor of Recurrence...

Peter Hofland, Ph.D - December 14, 2019

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Sacituzumab Govitecan in Metastatic Urothelial Cancer and Breast Cancer

Peter Hofland, Ph.D - September 30, 2019

Understanding Disparities in TNBC may Help to Better Inform Practice and...

Peter Hofland, Ph.D - July 10, 2019

First Patient Enrolled in Non-Pharmaceutical Multi-Center, Triple-Negative Breast Cancer Clinical Trial

Peter Hofland, Ph.D - June 10, 2019

One golden key on a background of different vintage keys; finding ways to unlock treatment for Triple-Negative Breast Cancer (TNBC).

Stopping Triple-negative Breast Cancer in its Tracks

Salman M. Hyder, PhD - May 24, 2019

No Significant Improvement in Early-stage TNBC Patients Treated with Adjuvant Capecitabine

Peter Hofland, Ph.D - December 7, 2018

Immunotherapy-chemotherapy Combination Improves Treatment of Aggressive Breast Cancer

Danielle Garcia - October 20, 2018

12 Page 1 of 2

LATEST NEWS

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Danielle Garcia - June 16, 2020

Press Releases | Cancer

FrontStream and MoveSpring Join Forces to Power the American Cancer... July 8, 2020
Through best-in-class wellness and fundraising solutions, FrontStream and MoveSpring enable some of the largest companies in North America to drive employee engagement and raise more funds for the...(PRWeb July 08, 2020)Read the full story at https://www.prweb.com/releases/frontstream_and_movespring_join_forces_to_power_the_american_cancer_societys_corporate_virtual_fitness_fundraising_event_the_fit2be_cancer_free_challenge/prweb17242681.htm
Childhood Cancer Foundation Names Tricia Martin To Its Board of... July 7, 2020
Bridge To A Cure Foundation announced Tricia Martin, RLA, LEED AP, as the latest addition to its Board of Directors.(PRWeb July 07, 2020)Read the full story at https://www.prweb.com/releases/childhood_cancer_foundation_names_tricia_martin_to_its_board_of_directors/prweb17229857.htm
Reaction from Cory Watson Attorneys: $10 Billion Settlement Reached in... July 1, 2020
Bayer, the maker of weed killer Roundup, will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its product causes cancer. Monsanto lost its first three Roundup trials...(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/reaction_from_cory_watson_attorneys_10_billion_settlement_reached_in_roundup_weed_killer_cancer_litigation/prweb17229746.htm
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches... July 1, 2020
Internal research programs to focus on building combination immunotherapies for brain cancer(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/silicon_beach_based_nonprofit_startup_cure_glioblastoma_launches_laboratory_operations_and_appoints_drs_john_boockvar_and_lisa_haile_as_senior_fellows/prweb17226957.htm
Lumeda Announces Formation of its Scientific Advisory Board July 1, 2020
Prominent medical and scientific experts to help company advance development of PDT products.(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/lumeda_announces_formation_of_its_scientific_advisory_board/prweb17222019.htm
Latest Data on IO Combinations Will Be Announced at the IO... June 30, 2020
IO Combinations 360°, organized by the Conference Forum, a combination-specific program, reports on the latest data and advancements to expedite more accurate therapies for patients faster taking...(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/latest_data_on_io_combinations_will_be_announced_at_the_io_combinations_360_conference_october_1_2_2020/prweb17225687.htm
Flagship Biosciences Launches New Clinical Diagnostics Service June 30, 2020
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient Care(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/flagship_biosciences_launches_new_clinical_diagnostics_service/prweb17223687.htm
AltruBio Inc. presented AbGn-107 Phase 1a chemo-refractory GI cancer... June 29, 2020
AltruBio Inc. http://www.altrubio.com, a clinical stage biotech company, has announced the presentation of AbGn-107 at the 2020 ASCO GI Cancer...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/altrubio_inc_presented_abgn_107_phase_1a_chemo_refractory_gi_cancer_results_at_asco_gi_2020/prweb17222550.htm
Dimensional Insight Announces Registration Sponsorship of St. Jude... June 29, 2020
Event benefits kids with childhood cancer, other life-threatening diseases at St. Jude Children’s Research Hospital(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/dimensional_insight_announces_registration_sponsorship_of_st_jude_walk_run_boston/prweb17222315.htm
iRECIST Criteria: An Operational Approach in Oncology Clinical Trials,... June 29, 2020
In this free webinar, the featured speakers will discuss concepts of establishing iUPD and iCPD by category and data scenarios across imaging time point visits. Attendees will learn about image case...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/irecist_criteria_an_operational_approach_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17222231.htm
The Lymphoma Research Foundation Hosts Inaugural Swirl: America, An At... June 29, 2020
LRF Spokesperson and Acclaimed Journalist Lisa Guerrero Kicks Off Nationwide Cheeseboard Challenge to Drive Lymphoma Awareness(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/the_lymphoma_research_foundation_hosts_inaugural_swirl_america_an_at_home_tasting_virtual_fundraiser/prweb17222149.htm
Managing Abnormal Results on Cervical Cancer Screening: ASCCP Issues... June 28, 2020
Published in Journal of Lower Genital Tract Disease, New Recommendations Focus on More Personalized Risk Assessment and Management(PRWeb June 28, 2020)Read the full story at https://www.prweb.com/releases/managing_abnormal_results_on_cervical_cancer_screening_asccp_issues_updated_guidelines/prweb17219257.htm
New US Patent Protects Key Element of First-in-Class Prodrug Candidate... June 26, 2020
Tumor-targeting and tumor-penetrating peptide enables EnduRx Pharmaceuticals novel prodrug for triple-negative breast cancer(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/new_us_patent_protects_key_element_of_first_in_class_prodrug_candidate_for_triple_negative_breast_cancer/prweb17214155.htm
PathAI and Bristol Myers Squibb find positive association of digital... June 26, 2020
Digital analysis shows higher sensitivity for PD-L1 expression and accurate detection of low-level PD-L1 expression in patients compared to manual reading(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/pathai_and_bristol_myers_squibb_find_positive_association_of_digital_pd_l1_expression_with_outcomes_in_nivolumab_treated_patients_in_an_exploratory_analysis/prweb17220807.htm

Tag: TNBC